StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Trailing 5-Quarter Average Equity by Year

Trailing 5-Quarter Average Equity ($M)

Thermo Fisher Scientific Trailing 5-Quarter Average Equity: $50,765M in FY2025, up 6.6% from a year earlier.

Latest, FY2025
50,765
Period ended Dec 31, 2025
Change on a year earlier
+6.6%
47,634 in FY2024
History
3 years
Since FY2023
Sources
1
Q3 2026 Reconciliation of Financial Information

Where the FY2025 figure comes from

“Trailing five quarters' average equity $ 44,443 $ 47,634 $ 50,765 $ 51,243 $ 51,908 $ 52,767”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package (Page 10 ROE).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTrailing 5-Quarter Average Equity ($M)Year on yearSource
FY2025Dec 31, 202550,765+6.6%Q3 2026 Reconciliation of Financial Information ↗
FY2024Dec 31, 202447,634+7.2%Q3 2026 Reconciliation of Financial Information ↗
FY2023Dec 31, 202344,443–Q3 2026 Reconciliation of Financial Information ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Trailing 5-Quarter Average Equity ($M), annual FY2023–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/roe-avg-equity-m

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.